Commercializing Living Therapies with CCRM
Hear from academic and industry experts sharing insider insights, information and trend forecasts for the cell and gene therapy industry. “Commercializing Living Therapies with CCRM” is brought to you by CCRM, a leader in developing, manufacturing and commercializing regenerative medicine-based technologies, and cell and gene therapies. Questions / comments? email: podcast@ccrm.ca.
Episodes
Featuring:
Molly Shoichet, PhD, O.C., O. Ont., FRS, University Professor and Pamela & Paul Austin Chair in Precision & Regenerative Medicine, University of Toronto
Audrey Greenberg, MBA, CEO & Founder, AG Capital Advisors
***
In this engaging episode of “Commercializing Living Therapies with CCRM,” we sit down with two leaders in the life sciences field: Molly Shoichet, a biomedical engineer and University Professor at the ...
Reni Benjamin, Managing Director, Healthcare Equity Research at Citizens
Brock Reeve, CEO and Co-founder, Eos BioInnovation
***
In this episode of Commercializing Living Therapies with CCRM, host Krista Lamb speaks with Reni Benjamin and Brock Reeve about the current financial landscape for cell and gene therapies (CGTs). They explore the unique dynamics companies face, from securing funding to navigating regulatory hurdles, and discu...
Featuring:
Silvio Tiziani, CEO, CCRM Australia
Sarah Callens, CTO, CCRM Nordic
***
In this episode of Commercializing Living Therapies with CCRM, Silvio Tiziani, CEO, CCRM Australia, and Sarah Callens, CTO, CCRM Nordic, explore the opportunities and challenges of commercializing regenerative medicines, including cell and gene therapies, in their respective regions. While scientific discoveries abound, barriers such as regulatory hurdle...
Featuring:
Durhane Wong-Rieger, PhD, President and CEO, Canadian Organization for Rare Disorders
Jacqueline Barry, PhD, Chief Clinical Officer, Cell and Gene Therapy Catapult
***
In this episode, we dive into the critical topic of enabling patient access to cell and gene therapies with two leaders in the field. Jacqueline Barry, an expert in the development and adoption of advanced therapies, shares her insights on the challenges invol...
Featuring:
Paul Knoepfler, PhD, Professor of Cell Biology and Human Anatomy, UC Davis School of Medicine
Amy Zarzeczny, PhD LLM, Associate Professor, Johnson Shoyama Graduate School of Public Policy, University of Regina
***
Unapproved stem cell therapies continue to be a significant concern in the regenerative medicine field. In this episode, Drs. Paul Knoepfler and Amy Zarzeczny discuss the issue. Listeners will hear the risks and im...
Featuring:
Christopher P. Boone, PhD, Group Vice President, Research Services, Health & Life Sciences, Oracle
Kenneth L. Harris, Chief Strategy Officer and Head of AI, OmniaBio Inc.
***
We are excited to share the first episode in the fourth season (!) of Commercializing Living Therapies with CCRM. A big thanks to all our listeners.
In this episode, we explore how artificial intelli...
Featuring:
Jacki Jenuth, PhD, Partner and COO, Lumira Ventures
Robin Quirk, PhD MBA, Vice President, Technology Sourcing and Venture Development, CCRM
***
In this episode, we explore the dynamics of venture capital (VC) and company creation with Jacki Jenuth, Partner and COO, Lumira Ventures, and Robin Quirk, Vice President, Technology Sourcing and Venture Development, CCRM. The conversation cove...
Featuring:
Michael Rosu-Myles, PhD, Executive Director, Health Canada
Josephine Lembong, PhD, Senior Manager, Science and Industry Affairs, Alliance for Regenerative Medicine
***
Currently, there are more than 2,000 cell and gene therapies in clinical trials worldwide. With a goal of ensuring that safe and quality products are approved for use by patients, regulators determine whether these innovative ther...
Featuring:
Sonia Sennik, Executive Director, Creative Destruction Lab
Glenn MacLean, Director, Technology Sourcing and Venture Development, CCRM
***
In many science-oriented fields, including regenerative medicine and advanced therapies, researchers and company founders often require additional support and expertise to successfully commercialize their discoveries.
With a mission of enhancing the commercialization of scie...
Featuring:
Matthew Durdy, Chief Executive Officer, Cell and Gene Therapy Catapult
Michael May, PhD, President and Chief Executive Officer, CCRM
***
Public-private partnerships are collaborations between government agencies and private-sector companies. In this interview, Matthew Durdy, CEO, Cell and Gene Therapy Catapult, and Michael May, President and CEO, CCRM, explain how these collaborations have had an impact in the rege...
Featuring:
Matthew Miller, B.M.Sc., PhD, Director, Michael G. DeGroote Institute for Infectious Disease Research; Co-Director, Canadian Pandemic Preparedness Hub (CP2H), McMaster University
Patrycja Thompson, PhD, Director, Strategy & Operations, the Canadian Hub for Health Intelligence & Innovation in Infectious Diseases (HI3), University of Toronto
***
The COVID-19 pandemic illuminated a need to scale up Canada’s biomanufact...
Featuring:
Mamatha Bhat MD, MSc, PhD, FRCPC
Hepatologist & Co-Lead of Transplant AI initiative (TAI), Ajmera Transplant Program Scientist, Toronto General Hospital Research Institute, University Health Network
Associate Professor, Division of Gastroenterology & Hepatology
Director, Clinician-Scientist Training Program (CSTP), Department of Medicine, University of Toronto
Partnerships & Engagemen...
Featuring:
Tom Whitehead, Co-Founder, Emily Whitehead Foundation.
Courtney Horvath, PhD, Global Head of Strategy, Planning & Operations, Translational Medicine, Novartis.
In this episode, we hear from two parents who supported their children through cancer treatments. Listeners will hear their unflinching accounts of what the children went through, underlining the urgent need for access to innovative and less...
Featuring:
Dr. Joerg Krueger, Medical Director, CAR T-Cell Program, The Hospital for Sick Children.
Dr. Bruce Levine, Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania Perelman School of Medicine.
Our guests discuss the future of CAR T-cell therapies, in a conversation covering autologous and allogeneic CAR T therapies. Drs. Krueger and Levine share their thoughts on which of these two approaches ...
Featuring:
Mark Taylor, Director of Commercialization, University Health Network
Dr. Irja Elliott Donaghue Technical & IP Specialist and Patent Agent, Notch Therapeutics
In the past, there was little evidence to challenge the idea that if a therapeutics developer did not hold a patent, it did not have anything to commercialize. In this episode, guests outline how the regenerative medicine industry changed that, proving the belief...
Featuring:
Dr. Dolores Baksh, CEO of TAAV Biomanufacturing Solutions
Susan Nichols, Chief Business Officer at ViroCell Biologics
As the cell and gene therapy industry continues to grow rapidly, Dolores Baksh and Susan Nichols emphasize the importance of nurturing a new workforce equipped with the skills to pivot and persevere—crucial qualities for the industry to grow. Join our guests as they discuss the significance of mentorshi...
Featuring:
Dr. Lise Munsie, Vice President, iPSC Technology Platform, CCRM
Dr. Stephen Sullivan, Programme Manager, Global Alliance for iPSC Therapies (GAiT)
Drs. Lise Munsie and Stephen Sullivan explore some of the biggest challenges that will need to be addressed to unlock the potential of induced pluripotent stem cells (iPSCs), from regulatory issues to quality assurance and safety. Listen to hear about the proactive appro...
Featuring:
Dr. Qasim Rafiq, Associate Professor in Cell and Gene Therapy Bioprocess Engineering, University College London (UCL)
Dr. Christine Allen, Vice-President, Ecosystem Development, adMare BioInnovations
Drs. Christine Allen and Qasim Rafiq offer insight on how to train and retain tomorrow’s cell and gene therapy (CGT) workforce in a very competitive space. We’ve witnessed an “explosion” of activity and they believe ...
How will Canada’s health care system pay for cell and gene therapy cures?
Featuring:
Dr. Chris McCabe, CEO and Executive Director, Institute of Health Economics
Robert Woolstencroft, Senior Director and Head, Market Access and Reimbursement, Gilead Sciences Canada
Our guests tackle the complex question of how therapy developers working at the cutting edge of regenerative medicine can get reimbursed when they deliver on t...
Examining the role ethical considerations and regulatory frameworks will play in regenerative medicine’s future.
Featuring:
Prof. Bartha Maria Knoppers, Canada Research Chair in Law and Medicine, and Director of the Centre of Genomics and Policy, Faculty of Medicine, McGill University
Siofradh McMahon, Director, Clinical Translation and Regulatory Affairs, CCRM
Join guests for a discussion about the responsibilities of the regenera...
Popular Podcasts
I’m Jay Shetty host of On Purpose the worlds #1 Mental Health podcast and I’m so grateful you found us. I started this podcast 5 years ago to invite you into conversations and workshops that are designed to help make you happier, healthier and more healed. I believe that when you (yes you) feel seen, heard and understood you’re able to deal with relationship struggles, work challenges and life’s ups and downs with more ease and grace. I interview experts, celebrities, thought leaders and athletes so that we can grow our mindset, build better habits and uncover a side of them we’ve never seen before. New episodes every Monday and Friday. Your support means the world to me and I don’t take it for granted — click the follow button and leave a review to help us spread the love with On Purpose. I can’t wait for you to listen to your first or 500th episode!
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
The official podcast of comedian Joe Rogan.
If you eat, sleep, and breathe true crime, TRUE CRIME TONIGHT is serving up your nightly fix. Five nights a week, KT STUDIOS & iHEART RADIO invite listeners to pull up a seat for an unfiltered look at the biggest cases making headlines, celebrity scandals, and the trials everyone is watching. With a mix of expert analysis, hot takes, and listener call-ins, TRUE CRIME TONIGHT goes beyond the headlines to uncover the twists, turns, and unanswered questions that keep us all obsessed—because, at TRUE CRIME TONIGHT, there’s a seat for everyone. Whether breaking down crime scene forensics, scrutinizing serial killers, or debating the most binge-worthy true crime docs, True Crime Tonight is the fresh, fast-paced, and slightly addictive home for true crime lovers.
The Clay Travis and Buck Sexton Show. Clay Travis and Buck Sexton tackle the biggest stories in news, politics and current events with intelligence and humor. From the border crisis, to the madness of cancel culture and far-left missteps, Clay and Buck guide listeners through the latest headlines and hot topics with fun and entertaining conversations and opinions.